Media headlines about Vascular Solutions (NASDAQ:VASC) have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Vascular Solutions earned a news sentiment score of 0.20 on Accern’s scale. Accern also assigned media headlines about the medical device company an impact score of 44.9926608490088 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Shares of Vascular Solutions (VASC) opened at 56.00 on Thursday. Vascular Solutions has a one year low of $25.06 and a one year high of $57.15. The company’s 50-day moving average is $55.89 and its 200-day moving average is $51.22.

WARNING: This news story was published by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-vascular-solutions-vasc-stock-price/1467466.html.

Vascular Solutions Company Profile

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Insider Buying and Selling by Quarter for Vascular Solutions (NASDAQ:VASC)

Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.